MOMENTUS INC (MNTS)

US60879E2000 - Common Stock

8.4  +0.31 (+3.83%)

Fundamental Rating

1

MNTS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 65 industry peers in the Aerospace & Defense industry. MNTS may be in some trouble as it scores bad on both profitability and health. MNTS is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

MNTS had negative earnings in the past year.
MNTS had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MNTS reported negative net income in multiple years.
In the past 5 years MNTS always reported negative operating cash flow.

1.2 Ratios

MNTS has a Return On Assets of -263.65%. This is amonst the worse of the industry: MNTS underperforms 98.46% of its industry peers.
Industry RankSector Rank
ROA -263.65%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of MNTS (78.33%) is better than 98.46% of its industry peers.
The Profit Margin and Operating Margin are not available for MNTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

MNTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for MNTS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -40.84, we must say that MNTS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -40.84, MNTS is doing worse than 93.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -40.84
ROIC/WACCN/A
WACC9.67%

2.3 Liquidity

A Current Ratio of 0.38 indicates that MNTS may have some problems paying its short term obligations.
The Current ratio of MNTS (0.38) is worse than 96.92% of its industry peers.
A Quick Ratio of 0.38 indicates that MNTS may have some problems paying its short term obligations.
MNTS has a Quick ratio of 0.38. This is amonst the worse of the industry: MNTS underperforms 93.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.38

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 91.22% over the past year.
MNTS shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.29%.
EPS 1Y (TTM)91.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.79%
Revenue 1Y (TTM)30.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-68.44%

3.2 Future

The Earnings Per Share is expected to grow by 3.15% on average over the next years.
The Revenue is expected to grow by 61.54% on average over the next years. This is a very strong growth
EPS Next Y74.76%
EPS Next 2Y3.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year63.1%
Revenue Next 2Y61.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MNTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MNTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.15%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOMENTUS INC

NASDAQ:MNTS (12/18/2024, 11:31:14 AM)

8.4

+0.31 (+3.83%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap256.70M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -263.65%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 78.33%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.38
Quick Ratio 0.38
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)91.22%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y74.76%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)30.29%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y